SUBJECT: THE EPIDEMIOLOGIC STUDY IN SAN VALENTINO
Maria Rosaria Cesarone, MD, Gianni Belcaro, MD, PhD, Andrea Di Renzo, BA, Mark Dugall, PhD, Marisa Cacchio, MD, Irma Ruffini, MD, Luciano Pellegrini, MD, Gilberto Del Boccio, MD, Filiberto Fano, BA, Andrea Ledda, MD, Angelica Bottari, MD, Andrea Ricci, MD, Stefano Stuard, MD, and Giulia Vinciguerra, PhD
From San Valentino-Spoltore Vascular Screening Project, Department of Biomedical Sciences, G D'anmmzio University, Chicti, Pescara, Italy
The efficacy of a 2-month treatment with oral colostrum in the prevention of flu episodes compared with anti-influenza vaccination was evaluated. Groups included healthy subjects without prophylaxis and those receiving both vaccination and colostrum. After 3 months of follow up, the number of days with flu was 3 times higher in the non-colostrum subjects. The colostrum group had 13 episodes versus 14 in the colostrum + vaccination group, 41 in the group without prophylaxis, and 57 in non-treated Subjects. Part 2 of the study had a similar protocol with 65 very high-risk cardiovascular subjects, all of whom had prophylaxis. The incidence of complications and hospital admission was higher in the group that received only a vaccination compared with the colostrum groups. Colostrum both in healthy subjects and high-risk cardiovascular patients, is at least 3 times more effective than vaccination to prevent flu and is very cost-effective.
Citation:
Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino.
Download document HERE.(PDF, 2.4 MB)
Cesarone MR - Clin Appl Thromb Hemost - 01-APR-2007; 13(2): 130-6